Get the latest news, insights, and market updates on CAI (Caris Life Sciences, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Caris Life Sciences announces collaborative new research on TET2
Caris Life Sciences (CAI) announced collaborative new research identifying TET2 clonal hematopoiesis, or CH, as a promising biomarker for improved response to immune checkpoint inhibitor, or ICI, therapy in patients with solid tumors. The study titled, ‘TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors,’ was led by Padmanee Sharma, at the James P. Allison Institute at The University of Texas MD Anderson Cancer Center Oct 30, 2025 - $CAI
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced collaborative new research identifying TET2 clonal hematopoiesis (CH) as a promising biomarker for improved response to immune checkpoint inhibitor (ICI) therapy in patients with solid tumors. The study titled, `TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors,' was led by Padma Oct 29, 2025 - $CAI
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, will unveil six studies at the European Society for Medical Oncology (ESMO) Congress 2025, in Berlin, Germany from October 17-21, 2025. These presentations highlight the transformative power of multiomics, a scientific approach that integrates data from multiple biological layers to achieve a comprehensive understanding of biological systems and disease. The research Oct 14, 2025 - $CAI
3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%
As the U.S. stock market navigates through a period of mixed performance with major indices setting new records despite challenges like a government shutdown, investors are keenly observing opportunities that may be undervalued amidst these fluctuations. In such an environment, identifying stocks that are trading at significant discounts can offer potential value, especially when considering broader economic factors and sector-specific developments. Oct 6, 2025 - $CAI
Caris Life Sciences, Inc. (CAI) Soars 81% YoY with $181M Q2 Revenue
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Caris Life Sciences, Inc. is one of them. Caris Life Sciences, Inc. (NASDAQ:CAI) is advancing its position as a leader in precision medicine by combining whole exome and transcriptome sequencing with AI-driven insights to support cancer detection, monitoring, and therapy […] Oct 1, 2025 - $CAI
Strong Performance Lifted Caris Life Sciences (CAI) in Q2
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in […] Sep 18, 2025 - $CAI
Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test
In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Caris Life Sciences, Inc. stands tenth among them. Caris Life Sciences, Inc. (NASDAQ:CAI) is a biotech company that is driven by its breakthroughs in precision oncology, expansion of AI-powered molecular diagnostics, and recent FDA approvals. […] Sep 11, 2025 - $CAI
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" lets us enhance your experience and provide personalized content and ads.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple